Genetic Analysis

New Oral Therapy Shows Promise for Advanced Endometrial Cancer
Research & Development New Oral Therapy Shows Promise for Advanced Endometrial Cancer

Patients who previously failed treatment with lenvatinib monotherapy showed a renewed response when the drug was paired with the novel experimental agent E7386. This breakthrough in gynecologic oncology represents a turning point for patients facing advanced endometrial cancer after exhausting

Biomimetic Nanomedicine Advances Colon Cancer Therapy
Biotech & Bioprocessing Biomimetic Nanomedicine Advances Colon Cancer Therapy

The integration of near-infrared light with gold nanoparticles allows clinicians to thermally destroy cancer cells from the inside out without harming surrounding tissue. This technological breakthrough addresses a critical need in oncology, as colon cancer currently maintains its position as one

FLOURISH Study Validates Osimertinib for Real-World Lung Cancer
Research & Development FLOURISH Study Validates Osimertinib for Real-World Lung Cancer

Baseline next-generation sequencing reveals that over 76 percent of lung cancer patients harbor additional genomic alterations that can shorten treatment durability. This statistic underscores the persistent challenge of managing advanced malignancies outside the sterile confines of traditional

FAO Renews MSU Status as Global Center for Aquatic Health
Management & Regulatory FAO Renews MSU Status as Global Center for Aquatic Health

University leaders recently met at the FAO headquarters in Rome to align their future strategic plans with global priorities for sustainable agri-food systems and animal health. This high-level assembly served as the backdrop for the formal announcement that the Food and Agriculture Organization of

Trend Analysis: DNA Damage Response in Aging
Research & Development Trend Analysis: DNA Damage Response in Aging

The biological quest for longevity has shifted from merely repairing "broken parts" to understanding the sophisticated software governing cellular life. Recent breakthroughs, highlighted by the "Guardian Paradox" framework, suggest that aging is not just an accumulation of damage, but a result of

Can AI Predict Outcomes Using Incomplete Multi-Omics Data?
Tech & Innovation Can AI Predict Outcomes Using Incomplete Multi-Omics Data?

Clinical practitioners frequently struggle with block-wise modality missingness, where budget constraints or technical failures prevent the collection of comprehensive molecular profiles for every patient. This foundational challenge arises in an era where the medical community seeks to transition

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later